Ipsen: all 356 studies
Page 4 of 4. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.
- A Study of the Potential Risk Factors Linked to the Development of Severe Forms of EndometriosisCompletedNCT01351051
- Study in Polish Acromegalic Patients Treated With Somatuline AutogelCompletedNCT01333384
- DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical DystoniaCompletedNCT01314365
- A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After StrokeTerminatedNCT01239628
- A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of DiarrheaCompletedNCT01234168
- Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast CancerTerminatedNCT01230970Phase 2
- Study of A3309 in Patients With DyslipidemiaCompletedNCT01069783Phase 2
- To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following StrokeCompletedNCT01020500
- Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical DystoniaCompletedNCT00833196
- BN83495 in Prostate CancerCompletedNCT00790374Phase 1
- Non Interventional Post Marketing Programme in Neuroendocrine TumoursCompletedNCT00747786
- IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of IncrelexTerminatedNCT00747604
- Non Interventional Post Marketing Programme in AcromegalyCompletedNCT00747500
- Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive FistulaeCompletedNCT00729313Phase 3
- Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study)CompletedNCT00710307
- Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational StudyCompletedNCT00686348
- Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive BladderTerminatedNCT00578097Phase 2
- Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG)WithdrawnNCT00517491Phase 2
- Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's DiseaseTerminatedNCT00500500Phase 2
- Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following SurgeryCompletedNCT00500227
- Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With AcromegalyCompletedNCT00499993Phase 3
- A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone DeficiencyCompletedNCT00455884
- A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth DisordersCompletedNCT00455728
- Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?TerminatedNCT00455637Phase 2
- Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With AcromegalyCompletedNCT00444873Phase 3
- Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)TerminatedNCT00444639Phase 2
- Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate CancerTerminatedNCT00415246Phase 3
- Effectiveness of Smecta in Combination With Oral Rehydration in the Treatment of Acute Watery Diarrhoea in Infants and ChildrenCompletedNCT00352989Phase 3
- Effectiveness of Smecta in the Treatment of Acute Diarrhoea in ChildrenCompletedNCT00352716Phase 3
- Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine TumoursCompletedNCT00326469Phase 2
- Efficacy and Safety Study of Dysport® Used for Migraine ProphylaxisCompletedNCT00301665Phase 2
- Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy TreatmentTerminatedNCT00288522Phase 2
- A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory ComplaintsCompletedNCT00276510Phase 4
- Study of Long-term Use of Forlax® in Elderly Patients With Chronic ConstipationCompletedNCT00276354Phase 4
- Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple SclerosisCompletedNCT00276341Phase 3
- Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in AdultsCompletedNCT00276328Phase 4
- Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial SpasmCompletedNCT00276315Phase 3
- To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence.CompletedNCT00255372Phase 3
- Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)CompletedNCT00247559Phase 2
- Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back PainCompletedNCT00246155Phase 3
- A Study of the Combination of Electrical Stimulation and Dysport® in Myofascial Pain Syndrome.CompletedNCT00246142Phase 3
- Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With AcromegalyCompletedNCT00234572Phase 2/3
- Asian Botulinum Clinical Trial Designed for Early Stroke SpasticityCompletedNCT00234546Phase 4
- A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or OctreotideCompletedNCT00234520
- Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential BlepharospasmCompletedNCT00234507Phase 2
- Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity of the ArmCompletedNCT00216411Phase 4
- Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LARCompletedNCT00216398Phase 4
- Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal CarcinomatosisCompletedNCT00216372Phase 3
- Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic PatientsCompletedNCT00210457Phase 3
- Efficacy Study of Dysport® in the Treatment of Anal Fissure.CompletedNCT00210444Phase 2
- Post Marketing Surveillance Study of DysportCompletedNCT00210431
- Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain SyndromeCompletedNCT00149240Phase 2
- Somatuline Autogel: Acromegaly Self/Partner Injection StudyCompletedNCT00149188Phase 4
- Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain SyndromeCompletedNCT00134810Phase 2
- Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid SyndromeTerminatedNCT00092287Phase 3
- Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)CompletedNCT00080015Phase 2